Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT06826807
What this trial is testing

Hepatic Elastography-Enhanced Lifestyle Modification in MASLD

Who this might be right for
Transient ElastographyMASLDBMI+4 more
Mahidol University 92
Large-scale testing (Phase 3)Study completedNCT06117137
What this trial is testing

The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus

Who this might be right for
Fatty Liver, Nonalcoholic
Sohag University 150
Not applicableNot Yet RecruitingNCT06757348
What this trial is testing

Fatty Liver and Pancreatic Steatosis

Who this might be right for
Exocrine Pancreatic InsufficiencyFatty Liver, NonalcoholicPancreatic Steatosis
Maria Marta Piskorz 61
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07466485
What this trial is testing

The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFLD)

Who this might be right for
Alcoholic Fatty Liver Disease
Universiti Kebangsaan Malaysia Medical Centre 26
Early research (Phase 1)Looking for participantsNCT07128797
What this trial is testing

A Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease（NAFLD）

Who this might be right for
NAFLD (Non-alcoholic Fatty Liver Disease)NASH (Nonalcoholic Steatohepatitis)
Tasly Biopharmaceuticals Co., Ltd. 32
Testing effectiveness (Phase 2)Ended earlyNCT04171765
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis

Who this might be right for
Non-alcoholic Steatohepatitis
Genentech, Inc. 46
Not applicableUnknownNCT02038387
What this trial is testing

Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Chronic Hepatitis C VirusNon Alcoholic Fatty Liver Disease
University of Roma La Sapienza 60
Large-scale testing (Phase 3)Study completedNCT02030977
What this trial is testing

The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Fatty Liver
Dr Azita Hekmatdoost 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07310407
What this trial is testing

Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
NAFLD
Ain Shams University 120
Not applicableUnknownNCT03613480
What this trial is testing

Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University Hospital of Patras 100
Post-approval studies (Phase 4)UnknownNCT01720719
What this trial is testing

Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty LiverDyslipidemiasDiabetes Mellitus
Xin Gao 120
Not applicableUnknownNCT03073343
What this trial is testing

A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon Insulin Dependent DiabetesALT
Southern California Institute for Research and Education 48
Testing effectiveness (Phase 2)Study completedNCT03517540
What this trial is testing

Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 193
Not applicableStudy completedNCT02962297
What this trial is testing

Vitamin E Versus Placebo for the Treatment of Non Diabetic Patients With Nonalcoholic Steatohepatitis

Who this might be right for
NASH (Non-Alcoholic Steatohepatitis)
Zhejiang Medicine Co., Ltd. 120
Post-approval studies (Phase 4)UnknownNCT05942963
What this trial is testing

Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType2diabetes
Jinnah Postgraduate Medical Centre 240
Not applicableStudy completedNCT04841915
What this trial is testing

Dairy Protien Rich Diet for NAFLD Patients

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseMetabolic SyndromeCaseins+4 more
University of Aarhus 46
Not applicableUnknownNCT02717000
What this trial is testing

NASH: Non-invasive Diagnostic Markers and Imaging

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Maastricht University Medical Center 110
Not applicableUnknownNCT06456970
What this trial is testing

Frequency of Metabolic Dysfunction Associated Fatty Liver Disease in Patients With Acute Coronary Syndromes

Who this might be right for
Fatty Liver
Assiut University 140
Not applicableStudy completedNCT05546450
What this trial is testing

Effect of Lyophilized Cornus Mas L. on Anthropometric and Biochemical Parameters in Metabolic Associated Fatty Liver Disease Patients

Who this might be right for
Fatty Liver DiseaseObesityLiver Fat
Istanbul Gelisim University 108
Not applicableUnknownNCT03426111
What this trial is testing

Multicenter, Randomized, Controlled and Double-blind Study of Efficacy and Safety of Endoscopic Gastric Tubulization in Patients With Non-alcoholic Steatohepatitis (NASH-APOLLO).

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseObesity
Puerta de Hierro University Hospital 40
Next Page